Skip to main content

Currently Skimming:

Appendix B: Committee Meeting Agendas
Pages 203-212

The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.


From page 203...
... Department of Health and Human Services' Office of Global Affairs) and the National Academy of Medicine's International Committee on Advancing Pandemic and Seasonal Influenza Preparedness and Response, on their perspective of the Statement of Task and to hear from relevant stakeholders • Hold an open session to obtain background from speakers on the current global landscape for implementing and financing influenza vaccination and its barriers • Discuss the Statement of Task and devise a committee work plan • Identify information needs and future meeting topics 203
From page 204...
... Department of Health and Human Services 9:10 a.m. Speaker 3 and Discussion: Envisioning Influenza at the World Health Organization: Global Frameworks and Partnerships for Influenza Vaccination Sylvie Briand Director, Global Infectious Hazard Preparedness World Health Organization 9:40 a.m.
From page 205...
... Framework and the Nagoya Protocol Sangeeta Shashikant Legal Advisor Third World Network 8:00 a.m. Speaker 3 and Discussion: Global Partnerships for Influenza Vaccination Jeremy Farrar Director Wellcome Trust 8:30 a.m.
From page 206...
... 9:35 a.m. Speaker 2 and Discussion: Potential Financing and Coordination Mechanisms for Pandemic Vaccination Nicole Lurie Strategic Advisor to the Chief Executive Officer, Coalition for Epidemic Preparedness Innovations (CEPI)
From page 207...
... Speaker 1: Governance Structures and Barriers in the African Region for Influenza Vaccine Manufacturing Patrick Tippoo Executive Committee Vice President, Develop ing Country Vaccine Manufacturing Network (DCVMN) Founding Member, African Vaccine Manufactur ers Initiative (AVMI)
From page 208...
... EDT) : Full committee session Meeting Objectives • Hold open sessions to obtain background from speakers on the current barriers for effective global health governance for pandemic influenza vac cination, with a focus on pathogen sharing regulations, technology transfer partnerships, and global access and financing • Hold working group deliberations to form initial recommendations • Hold whole-committee meeting to discuss initial recommendations and next steps Thursday, May 6, 2021 OPEN SESSION 1: TECHNOLOGY AND MANUFACTURING WORKING GROUP 8:25 a.m.
From page 209...
... Welcome and Introductions Alexandra Phelan Assistant Professor Center for Global Health Science and Security Georgetown University 9:35 a.m. Speaker 1: Speed and Equity for Pathogen and Vaccine Sharing at the World Health Organization Steven Solomon Principal Legal Officer, World Health Organization 10:00 a.m.
From page 210...
... Opening Remarks Amanda Glassman Senior Fellow and Executive Vice President Center for Global Engagement 9:05 a.m. Speaker 1: Lessons from Economic Theory: Developing Quick Pandemic Vaccines and Distributing Them Equitably Gavin Yamey Associate Director for Policy and Professor of the Practice of Global Health and Public Policy Director, Center for Policy Impact in Global Health Duke Global Health Institute David McAdams Professor of Business Administration, Fuqua School of Business Professor of Economics, Economics Department Duke University Osondu Ogbuoji Assistant Research Professor Deputy Director, Center for Policy Impact in Global Health Duke Global Health Institute
From page 211...
... International Influenza Vaccine Technology Manufacturing Capacity Program Julie Schafer Chief Technology Officer Flu Lab Erin Sparrow Technical Officer World Health Organization 1:45 p.m. Closing Remarks


This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
More information on Chapter Skim is available.